Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus

Clinical trial NCT06057077 · UNKNOWN

Trial details

NCT number: NCT06057077
Sponsor: Ministry of Health, Saudi Arabia
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2024-01-01
Primary completion: 2024-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.